视野：一项雷珠单抗治疗继发于年龄相关黄斑变性脉络膜新生血管形成的开放标签延伸试验

Article Outline

• Abstract
• Material and Methods
  • Study Design
    • Intervention and Retreatment Criteria
    • Outcome Measures
    • Analysis Populations
  • Examination Procedures and Laboratory Assessments
  • Statistical Methods
• Results
  • Primary Outcome Measures
    • Ocular Safety
    • Nonocular Safety
  • Vision Results
    • Factors Associated with Clinically Significant Long-term Visual Acuity Gains
• Discussion
• Supplementary data
• References
• Copyright

Objective

To evaluate the long-term safety and efficacy of multiple intravitreal ranibizumab injections (Lucentis, Genentech, Inc., South San Francisco, CA) administered at the investigator's discretion in patients with choroidal neovascularization secondary to age-related macular degeneration.

Design

An open